Arlo Technologies, Inc. — Form 8-K
Filed August 6, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 48/100
What the filing says
Arlo reported Q2 2026 total revenue of $156.0M (up 21% YoY) with record subscriptions/services revenue of $93.0M (up 19% YoY). Non-GAAP gross margin expanded 480 bps to 50.6%, and adjusted EBITDA reached $31M (20% margin). The company raised full-year 2026 guidance to $580–$600M revenue and non-GAAP EPS of $0.90–$1.00. Cash/investments stand at $141.1M after $48.2M acquisition (Aloe Care Health) and $22M stock repurchase.
Why this rating
Strong organic growth (21% revenue, 19% subscriptions) and margin expansion with $0.90–$1.00 FY EPS guidance are meaningful. However, relative to $1.5B market cap, this represents ~10% implied annual revenue run-rate and modest absolute EBITDA. Acquisition integrates adjacent health service but doesn't reshape core security business. Positive but not transformational.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.